InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
45%
T+90 mean return
-1.8%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by GALLAHUE KIERAN, Director. Insider active across 4 companies, notably Edwards Lifesciences Corp. Aggregated, 21 filings have been recorded. Activity tracked since 7 May 2021. The latest transaction was disclosed on 19 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations21 total
9,330 shares0Common StockSEC:0001308428-26-000003:0
3,528 shares0Common StockSEC:0001225208-25-004951:0
10,085 shares0Common StockSEC:0001757073-24-000055:0
3,055 shares0Common StockSEC:0001225208-24-005893:0
7,056 shares@ US$36.863316.1% of flowCommon StockSEC:0001225208-24-002963:0
5,425 shares0Common StockSEC:0001757073-23-000047:0
2,803 shares0Common StockSEC:0001225208-23-005906:0
4,435 shares0Common StockSEC:0001757073-22-000075:0
3,239 shares@ US$28.25100.0% of flowCommon StockSEC:0001562180-22-004073:0
2,300 shares0Common StockSEC:0001225208-22-006786:0
3,628 sharesCommon StockSEC:0001628280-22-005915:0
32,256 shares@ US$22.28670.0013% mcap100.0% of flowCommon StockSEC:0001225208-22-001657
32,256 shares@ US$22.28670.0013% mcap50.0% of flowCommon StockSEC:0001225208-22-001657:0
3,067 shares0Common StockSEC:0001628280-21-012283:0
3,067 shares0Common StockSEC:0001628280-21-012283
3,239 shares0Common StockSEC:0001562180-21-004111:0
3,239 shares0Common StockSEC:0001562180-21-004111
4,020 shares0Common StockSEC:0001757073-21-000078:0
4,020 shares0Common StockSEC:0001757073-21-000078
2,615 shares0Common StockSEC:0001225208-21-007755
2,615 shares0Common StockSEC:0001225208-21-007755:0
21 of 21 declarations
About GALLAHUE KIERAN
Kieran Gallahue is a Board Member at Edwards Lifesciences Corp, Envista Holdings Corp, and Intersect ENT, Inc. He brings expertise in strategy and business development, influencing key decisions within these companies.
